SE7702332L - Forfarande for framstellning av cefalosporinforeningar - Google Patents

Forfarande for framstellning av cefalosporinforeningar

Info

Publication number
SE7702332L
SE7702332L SE7702332A SE7702332A SE7702332L SE 7702332 L SE7702332 L SE 7702332L SE 7702332 A SE7702332 A SE 7702332A SE 7702332 A SE7702332 A SE 7702332A SE 7702332 L SE7702332 L SE 7702332L
Authority
SE
Sweden
Prior art keywords
cephalosporine
associations
procedure
preparation
cephalosporine associations
Prior art date
Application number
SE7702332A
Other languages
English (en)
Other versions
SE433081B (sv
Inventor
H Yamada
T Nakagome
T Komatsu
Original Assignee
Sumitomo Chemical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP2348576A external-priority patent/JPS52106895A/ja
Priority claimed from JP2348476A external-priority patent/JPS52106889A/ja
Priority claimed from JP2348276A external-priority patent/JPS52106888A/ja
Priority claimed from JP2348376A external-priority patent/JPS52106894A/ja
Application filed by Sumitomo Chemical Co filed Critical Sumitomo Chemical Co
Publication of SE7702332L publication Critical patent/SE7702332L/sv
Publication of SE433081B publication Critical patent/SE433081B/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
SE7702332A 1976-03-03 1977-03-02 Forfarande for framstellning av cefalosporinforeningar SE433081B (sv)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP2348576A JPS52106895A (en) 1976-03-03 1976-03-03 77*nnacylaminooaaaryl orrthienylacetamido**33*heterocyclic thiomethyl* 33cephemm44carboxylic acids
JP2348476A JPS52106889A (en) 1976-03-03 1976-03-03 7-(n-acylamino-alpha-aryl or-thienylacetamido)-3-carbamoyl-3-cephem-4-carb oxylic acids
JP2348276A JPS52106888A (en) 1976-03-03 1976-03-03 7-(n-acylamino-alpha-arylacetamido0-3-azidomethyl acid
JP2348376A JPS52106894A (en) 1976-03-03 1976-03-03 7-(n-acylamino-alpha-aryl or-thienylacetamido)-3-(heterocyclic-thiomethyl) acids

Publications (2)

Publication Number Publication Date
SE7702332L true SE7702332L (sv) 1977-09-04
SE433081B SE433081B (sv) 1984-05-07

Family

ID=27457971

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7702332A SE433081B (sv) 1976-03-03 1977-03-02 Forfarande for framstellning av cefalosporinforeningar

Country Status (17)

Country Link
US (1) US4165373A (sv)
AT (3) AT359186B (sv)
AU (1) AU498968B2 (sv)
BE (1) BE851983A (sv)
CA (1) CA1120466A (sv)
CH (1) CH621125A5 (sv)
DE (1) DE2709293A1 (sv)
DK (1) DK91277A (sv)
ES (2) ES456499A1 (sv)
FR (1) FR2342734A1 (sv)
GB (1) GB1537949A (sv)
HU (1) HU176615B (sv)
MX (1) MX5388E (sv)
NL (1) NL7702222A (sv)
NO (1) NO770703L (sv)
NZ (1) NZ183477A (sv)
SE (1) SE433081B (sv)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH634848A5 (de) * 1976-08-17 1983-02-28 Fujisawa Pharmaceutical Co Verfahren zur herstellung neuer 7-(n-substituierter 2-phenylglycinamido)-3-substituierte-3-cephem-4-carbonsaeuren.
JPS5492991A (en) 1977-12-28 1979-07-23 Dainippon Pharmaceut Co Ltd N-acyl cephalosporin derivative and its salt
FR2387235A1 (fr) * 1978-01-23 1978-11-10 Fujisawa Pharmaceutical Co Procede de preparation de composes d'acide 3,7-disubstitue-3-cephem-4-carboxylique et nouveaux produits ainsi obtenus, ayant une forte activite antibacterienne
JPS6058239B2 (ja) * 1978-07-20 1985-12-19 山之内製薬株式会社 新規セフアロスポリン誘導体
JPS55139389A (en) * 1979-04-19 1980-10-31 Mitsui Toatsu Chem Inc Novel cephalosporin
JPS5572195A (en) * 1978-11-28 1980-05-30 Mitsui Toatsu Chem Inc Novel cephalosporin and antibacterial comprising it as active constituent
US4420477A (en) * 1979-11-30 1983-12-13 Fujisawa Pharmaceutical Co., Ltd. Cephem compounds
US4288590A (en) * 1980-02-14 1981-09-08 Bristol-Myers Company 7-[Dα-(4-Hydroxy-1,5-naphthyridine-3-carboxamido)-α-arylacetamido]-3-(N,N-dimethyl-aminomethylpyridinium) methyl-3-cephem-4-carboxylates
CA1152489A (en) * 1980-03-05 1983-08-23 Takao Okuda ANTIMICROBIAL 7- (.alpha.-ACYLAMINO-.alpha.-ARYLACETAMIDO)-3- (SUBSTITUTED METHYL) CEPHALOSPORIN COMPOUNDS, THEIR COMPOSITIONS AND PRODUCTION THEREOF
ES499978A0 (es) * 1980-03-05 1982-01-01 Sumitomo Chemical Co Procedimiento de producir compuestos cefalosporinicos anti- microbianos
JPS56158791A (en) * 1980-05-10 1981-12-07 Taisho Pharmaceut Co Ltd Cephalosporin compound
WO2002086143A2 (en) * 2001-04-19 2002-10-31 Bioferma Murcia, S.A. Enzymatic process for preparing cephalosporin derivatives

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5747672B2 (sv) * 1973-10-13 1982-10-12
JPS5119765A (en) * 1974-08-09 1976-02-17 Takeda Chemical Industries Ltd Aminochiazoorujudotaino seizoho
JPS51115491A (en) * 1975-04-03 1976-10-12 Sumitomo Chem Co Ltd Method for preparing 77* *44hydroxyy1*5 naphthyridinee33carboxyamino ** phenylacetamido*cephalosporins
US4045438A (en) * 1975-10-24 1977-08-30 Yeda Research And Development Co. Ltd. Cephalosporin antibiotics
US4025626A (en) * 1975-12-09 1977-05-24 Smithkline Corporation 7-Acyl-3-(ureidoalkyl substituted tetrazolylthiomethyl)-cephalosporins

Also Published As

Publication number Publication date
DE2709293A1 (de) 1977-09-08
ATA198779A (de) 1980-03-15
US4165373A (en) 1979-08-21
GB1537949A (en) 1979-01-10
DK91277A (da) 1977-09-04
AT359193B (de) 1980-10-27
CH621125A5 (sv) 1981-01-15
ES456499A1 (es) 1978-11-16
ES468662A1 (es) 1979-11-01
AT359194B (de) 1980-10-27
FR2342734A1 (fr) 1977-09-30
ATA140077A (de) 1980-03-15
BE851983A (fr) 1977-07-01
HU176615B (en) 1981-03-28
AU2281377A (en) 1978-09-07
AT359186B (de) 1980-10-27
SE433081B (sv) 1984-05-07
AU498968B2 (en) 1979-03-29
ATA198679A (de) 1980-03-15
MX5388E (es) 1983-07-07
NO770703L (no) 1977-09-06
CA1120466A (en) 1982-03-23
FR2342734B1 (sv) 1981-06-19
NL7702222A (nl) 1977-09-06
NZ183477A (en) 1979-06-19

Similar Documents

Publication Publication Date Title
SE441827B (sv) Forfarande for framstellning av fenoxiaminopropanoler
SE433208B (sv) Forfarande for framstellning av fenoletrar
NO774404L (no) Fremgangsmaate for fremstilling av dimetyleter
SE441354B (sv) Forfarande for framstellning av meta-fenoxibensaldehyd
SE435387B (sv) Forfarande for framstellning av antracyklinglykosider
NO143992C (no) Fremgangsmaate for fremstilling av heksanitrostilben
NO821848L (no) Fremgangsmaate for fremstilling av gamma-pyron-derivater
SE437833B (sv) Forfarande for framstellning av 7-beta-oxiiminoacylcefalosporiner
SE7702332L (sv) Forfarande for framstellning av cefalosporinforeningar
NO772960L (no) Fremgangsmaate til fremstilling av cefalosporinderivater
NO774067L (no) Fremgangsmaate for fremstilling av cellulosemasse
SE7707471L (sv) Forfarande for framstellning av 5-m-tolyloxiuracil
SE7712218L (sv) Forfarande for framstellning av 4a-aryloktahydro-1h-2-pyrindiner
SE7802530L (sv) Forfarande for framstellning av cefalosporinforeningar
SE435380B (sv) Forfarande for framstellning av kinazolinforeningar
SE7702071L (sv) Forfarande for framstellning av sulfoacetaler
SE7709142L (sv) Forfarande for framstellning av 1-aryloxi-3-amino-propan-2-oler
SE7709636L (sv) Forfarande for framstellning av 4-oxokapronitril
SE7701667L (sv) Forfarande for framstellning av cefalosporin-antibiotika
SE7700572L (sv) Forfarande for framstellning av tienopyridinderivat
SE436496B (sv) Forfarande for framstellning av dibensotiofenderivat
SE443143B (sv) Forfarande for framstellning av arylmalonamido-1-oxadetiacefalosporiner
SE7705447L (sv) Forfarande for framstellning av tioetrar
SE7714872L (sv) Forfarande for framstellniong av halogenacylamider
NO774147L (no) Fremgangsmaate for fremstilling av kinazolinonforbindelser